Association of British Healthcare Industries

Media Centre :: Press Releases

01/01/02 ABHI calls for clarity in NICE'S role

"The publication of the House of Commons Health Select Committee report into NICE has addressed several concerns often expressed by the Association of British Healthcare Industries (ABHI)", Director-General Gordon Aylward said today.

Coinciding with this report is the news that NICE is also consulting on the future review of new surgical procedures. It has taken responsibility for the Safety and Efficacy Register of New Interventional Procedures (SERNIP) but it is not clear how NICE will avoid duplication and the creation of new market barriers.

Gordon Aylward said: "The majority of new surgical procedures exist because there are new medical devices. These procedures are consequently regulated through existing regulation enforced by the Medical Devices Agency (MDA). There is no role for NICE in this part of the process"

The role of NICE in assessing technologies and the suggestion from the Health Select Committee report regarding implementation and monitoring of NICE recommendations is fully endorsed by the ABHI. It is the view of the health-care industry that if patients are going to realise the benefits of this sophisticated appraisal system, there must be better execution of decisions.

The Select Committee's report makes a call for the consideration of wider societal costs and advantages of particular treatments and in particular the wider costs and benefits to the public purse of reduced benefit dependency and improved ability to work

ABHI have long been campaigning for a new paradigm of cost evaluations where the cost of the patient/user wellness is not calculated simply on the cost of the treatment, but on the reduced dependency of the patient on the social system", Mr Aylward said.

A full copy of the ABHI response on SERNIP and a list of key points from the Select Committee's report are available to ABHI members.


Notes for editors:

* The Association of British Healthcare Industries (ABHI) is the lead trade association for the medical systems industry. This sector comprises not only manufacturers of medical devices, equipment and consumables, but also service companies, distributors, professional groups (such as regulatory consultants and lawyers), and other suppliers to the medical community.

* The ABHI represents approx. 200 member companies with a total domestic turnover of about £3 billion representing approx. 80% of the industry output. 

* The membership currently includes several Special Interest Sections and four sectoral trade associations, which in turn have a further 400 member companies.

* Member list: www.abhi.org.uk

* The role of the Association is to:
  - Advance and promote medical systems (devices, equipment, technologies and services) within the UK and globally.
  - Provide a forum for policy discussion with the industry's customers, legislators, public bodies and interested groups.

For further information contact:
Daniel Jones: 020 7960 4360
Email: daniel.jones@abhi.org.uk

back to previous

Last updated: 02/02/2005 10:33:47